Amedeo's Top 20

Amedeo Smart

Independent Medical Education

22 May 2023

Multidisciplinary Journal Club

  1. Richardson TL Jr, Halvorson AE, Hackstadt AJ, Hung AM, et al.
    Primary Occurrence of Cardiovascular Events After Adding Sodium-Glucose Cotransporter-2 Inhibitors or Glucagon-like Peptide-1 Receptor Agonists Compared With Dipeptidyl Peptidase-4 Inhibitors: A Cohort Study in Veterans With Diabetes.
    Ann Intern Med 2023.

  1. Galper BZ, Chinnakondepalli KM, Wang K, Magnuson EA, et al.
    Economic Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis and Low Surgical Risk: Results from the PARTNER 3 Trial.
    Circulation 2023.

  2. Romanowski K, Law MR, Karim ME, Campbell JR, et al.
    Healthcare utilization after respiratory tuberculosis: a controlled interrupted time series analysis.
    Clin Infect Dis 2023.

  3. Scagliotti GV, Parikh P, von Pawel J, Biesma B, et al.
    Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non-Small-Cell Lung Cancer.
    J Clin Oncol 2023;41:2458-2466.

  4. Patuzzo R, Mattavelli I, Gallino G, Galeone C, et al.
    The prognostic role of mitotic rate in cutaneous malignant melanoma: Evidence from a multicenter study on behalf of the Italian Melanoma Intergroup.
    Cancer 2023.

  1. Travis J.
    Latest Alzheimer's antibody is 'not a miracle drug'.
    Science 2023;380:571.

  2. Sattar N, McMurray J, Boren J, Rawshani A, et al.
    Years of Cardiovascular Complications and Risk Factors in Patients With Type 2 Diabetes: A Nationwide Swedish Cohort Study.
    Circulation 2023.

  3. Yan W, Qin C, Tao L, Guo X, et al.
    Association between inequalities in human resources for health and all cause and cause specific mortality in 172 countries and territories, 1990-2019: observational study.
    BMJ 2023;381:e073043.

  4. Amir J, Chodick G, Pardo J.
    Revised protocol for secondary prevention of congenital cytomegalovirus infection with valaciclovir following infection in early pregnancy.
    Clin Infect Dis 2023.

  5. Kwan TW, Wong SS, Hong Y, Kanaya AM, et al.
    Epidemiology of Diabetes and Atherosclerotic Cardiovascular Disease Among Asian American Adults: Implications, Management, and Future Directions: A Scientific Statement From the American Heart Association.
    Circulation 2023.

  1. Jervan O, Haukeland-Parker S, Gleditsch J, Tavoly M, et al.
    The effects of exercise training in patients with persistent dyspnoea after pulmonary embolism: a randomized controlled trial.
    Chest 2023.

  2. Surial B, Chammartin F, Damas J, Calmy A, et al.
    Impact of integrase inhibitors on cardiovascular disease events in people with HIV starting antiretroviral therapy.
    Clin Infect Dis 2023.

  3. Xie Y, Choi T, Al-Aly Z.
    Molnupiravir and risk of post-acute sequelae of covid-19: cohort study.
    BMJ 2023;381:e074572.

  4. Stoop TF, Bergquist E, Theijse RT, Hempel S, et al.
    Systematic review and Meta-analysis of the Role of total Pancreatectomy as an Alternative to Pancreatoduodenectomy in Patients at High Risk for Postoperative Pancreatic Fistula: is it a Justifiable Indication?
    Ann Surg 2023.

  5. Butler J, Packer M, Siddiqi TJ, Bohm M, et al.
    Efficacy of Empagliflozin in Patients With Heart Failure Across Kidney Risk Categories.
    J Am Coll Cardiol 2023;81:1902-1914.

  1. .
    Reply: Epidemiological cut-off values for a 96-well broth microdilution plate for high-throughput research antibiotic susceptibility testing of M. tuberculosis.
    Eur Respir J 2023;61.

  2. Robinson JA, Mahmud FJ, Greif E, Toribio M, et al.
    Osteopontin is an integral mediator of cardiac interstitial fibrosis in models of HIV infection.
    J Infect Dis 2023.

  3. Durstenfeld MS, Peluso MJ, Kaveti P, Hill C, et al.
    Reduced exercise capacity, chronotropic incompetence, and early systemic inflammation in cardiopulmonary phenotype Long COVID.
    J Infect Dis 2023.

  4. Hakeem H, Alsfouk BAA, Kwan P, Brodie MJ, et al.
    Should substitution monotherapy or combination therapy be used after failure of the first antiseizure medication? Observations from a 30-year cohort study.
    Epilepsia 2023;64:1248-1258.

  5. Anstee QM, Lucas KJ, Francque S, Abdelmalek MF, et al.
    Tropifexor plus cenicriviroc combination versus monotherapy in non-alcoholic steatohepatitis: Results from the Phase 2b TANDEM study.
    Hepatology 2023.


more..

Privacy Policy